CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that John P. Butler, President and Chief Executive Officer, will present at the 2015 JMP Securities Life Sciences Conference on Tuesday, June 23 at 3:00 p.m. Eastern Time. The conference will take place at The St. Regis New York in New York City.
Help employers find you! Check out all the jobs and post your resume.
